What it measures.
Homocysteine is a sulfur-containing amino acid produced during methionine metabolism. Elevated levels damage blood vessel walls, promote oxidative stress, and increase thrombosis risk. It's a sensitive indicator of B-vitamin status (B12, folate, B6) and methylation function.
The concentration of homocysteine in blood. It reflects the efficiency of the methylation cycle, which depends on adequate B vitamins for proper function.
Why it matters.
Each standard deviation increase in homocysteine is associated with increased stroke and cardiovascular risk in observational studies. Elevated homocysteine is also a marker of impaired methylation (B-vitamin status). However, an important clinical caveat: B-vitamin supplementation reliably lowers homocysteine levels, but large RCTs and meta-analyses have consistently shown that lowering homocysteine with B vitamins does NOT reduce myocardial infarction risk or all-cause mortality (PMID:22652362). The cardiovascular prevention rationale for treating elevated homocysteine is therefore weak — it is a useful biomarker of B-vitamin status and methylation, but not an established therapeutic target for CV disease prevention.
Physiology.
Homocysteine is produced when methionine loses its methyl group. It can be recycled back to methionine (requires folate and B12) or converted to cysteine (requires B6). MTHFR gene variants reduce folate activation, impairing homocysteine recycling and raising levels.
Testing & preparation.
How to prepare
- Fasting preferred (8-12 hours)
- Avoid B-vitamin supplements for 24 hours if assessing baseline
- Sample should be processed quickly (homocysteine rises in stored samples)
When to test
Cardiovascular risk assessment, family history of early heart disease, history of stroke/clots, B-vitamin deficiency evaluation, or MTHFR assessment.
How often
At baseline; recheck 2-3 months after starting B-vitamin supplementation.
Interpretation.
High homocysteine
Common causes:
- B12 deficiency
- Folate deficiency
- B6 deficiency
- MTHFR gene variants
- Kidney disease
- Hypothyroidism
- Medications (metformin, PPIs, anticonvulsants)
- Smoking, excessive alcohol
Implications:
- Increased cardiovascular disease risk
- Higher stroke risk
- Vascular damage and inflammation
- May indicate impaired methylation
- Usually responds to B-vitamin therapy
Low homocysteine
Common causes:
- Normal finding
- B-vitamin supplementation
Implications:
- Generally favorable for cardiovascular health
Optimization.
Diet
- Folate-rich foods (leafy greens, legumes, fortified grains)
- B12 from animal products or fortified foods
- B6 from poultry, fish, potatoes, bananas
- Limit excessive protein intake
Lifestyle
- Quit smoking
- Limit alcohol
- Reduce coffee if excessive
- Address underlying conditions
Supplements
- Methylfolate (5-MTHF) 400-800mcg especially with MTHFR variants
- Methylcobalamin (B12) 500-1000mcg
- Pyridoxal-5-phosphate (B6) 25-50mg — note: chronic high-dose B6 (typically >50mg/day, sometimes lower) can cause sensory peripheral neuropathy; use conservative doses and do not exceed without medical supervision
- TMG (trimethylglycine) for additional support
FAQs.
Do I have an MTHFR mutation if my homocysteine is high?
Not necessarily. While MTHFR variants (especially C677T) can elevate homocysteine by 30-60%, many other factors contribute: B12/folate/B6 deficiency, kidney disease, hypothyroidism, medications, and lifestyle factors. High homocysteine often responds to B-vitamin supplementation regardless of MTHFR status. Genetic testing is optional—treating with methylated B vitamins addresses the issue either way.
How quickly can homocysteine improve with supplementation?
Homocysteine typically responds within 2-4 weeks of starting adequate B-vitamin supplementation, with maximum reduction by 6-8 weeks. Methylated forms (methylfolate, methylcobalamin) may work better for those with MTHFR variants. Retest 2-3 months after starting supplementation to confirm improvement. Important caveat: while B vitamins lower the homocysteine number, RCTs have not shown this translates to reduced heart attack risk — so treating elevated homocysteine mainly addresses B-vitamin deficiency, not cardiovascular disease directly.